 GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector Atishay Ltd empanelled as Business Associate with RailTel
Atishay Ltd empanelled as Business Associate with RailTel 
              Dishman Pharmaceuticals & Chemicals Ltd has announced that the Board of Directors of the Company at its meeting held on July 18, 2007, inter alia, has allotted 25,32,555 equity shares of Rs 2/- each to the Company at a premium of Rs 170/- per equity share upon exercise of option of conversion by the FCCB holders for conversion of 0.50% Foreign Currency Convertible Bonds (FCCB) of the principal amount of US$ 10,000,000 into the equity shares of the Company.
Consequently, the paid-up equity share capital of the Company has increased from 73732607 equity shares of Rs 2/- each to 76265162 equity shares of Rs 2/- each.
The stock closed the day at Rs.335.05, up by Rs.4.60 or 1.39%. The stock hit an intraday high of Rs.336 and low of Rs.328. The total traded quantity was 10937 compared to 2 week average of 58428.